Skip to content

Clinical trials

Phase 3 Hearing Loss, Sensorineural trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hearing Loss, Sensorineural Phase: Phase 3 Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20151
20161
20171
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated3
Completed2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dr. Ann C.T.M. Vossen2
Auris Medical AG1
Auris Medical, Inc.1
Eli Lilly and Company1
Hospital Italiano de Buenos Aires1
National Institute on Deafness and Other Communication Disorders (NIDCD)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hearing Loss, Sensorineural7
Deafness3
Hearing Loss3
Cytomegalovirus Infections2
Ear Diseases2
Hearing Disorders2
Hearing Loss, Unilateral2
Otorhinolaryngologic Diseases2
Sensation Disorders2
Signs and Symptoms2

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.